October 15, 2019
Mitokinin today announced that The Michael J. Fox Foundation has awarded the Company a $300,000 grant to advance…
October 1, 2019
Mitokinin, a late-preclinical stage biotechnology company developing PINK1-targeted therapies for…
June 15, 2019
Copyright © 2019 Mitokinin. All rights reserved.
Website designed and developed by RainCastle Communications, Inc.